The heteroplasmic 15059G>A mutation in the mitochondrial cytochrome b gene and essential hypertension in type 2 diabetes

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 6, Issue 3, 2012, Pages 150-156

  Nikitin, Alexey G ^a   Lavrikova, Elena Y ^a,b   Chistiakov, Dimitry A ^c  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

15059G>A mutation; Cytochrome b; Essential hypertension; Heteroplasmy; Mitochondrial DNA

Indexed keywords

CYTOCHROME B; MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; DNA ISOLATION; ESSENTIAL HYPERTENSION; FEMALE; GENE MUTATION; HETEROPLASMY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CYTOCHROMES B; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOSCOW; MUTATION; OXIDATIVE STRESS; PEDIGREE; PHENOTYPE; RISK FACTORS;

EID: 84869476211     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2012.09.005     Document Type: Article

References (46)

1. R. Belostotsky, E. Ben-Shalom, C. Rinat, R. Becker-Cohen, S. Feinstein, and S. Zeligson Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome American Journal of Human Genetics 88 2011 193 200
2. Ile A4295G mutation in a Chinese family Biochemical and Biophysical Research Communications 367 2008 906 911
3. Gln metabolism caused by the novel 4401A>G mutation are involved in essential hypertension in a Han Chinese Family Hypertension 54 2009 329 337
4. Y. Liu, Z. Li, L. Yang, S. Wang, and M.X. Guan The mitochondrial ND1 T3308C mutation in a Chinese family with the secondary hypertension Biochemical and Biophysical Research Communications 368 2008 18 22
5. Met 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree Hypertension 53 2009 1083 1090
6. Ile gene in a large Han Chinese family Circulation Research 108 2011 862 870
7. Met 4435A>G mutation in the mitochondrial haplogroup G2a1 is responsible for maternally inherited hypertension in a Chinese pedigree European Journal of Human Genetics 19 2011 1181 1186
8. American Diabetes Association Treatment of hypertension in adults with diabetes Diabetes Care 26 Suppl. 1 2007 S80 S82
9. G.B. Ehret Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension Current Hypertension Reports 12 2010 17 25
10. D. Levy, G.B. Ehret, K. Rice, G.C. Verwoert, L.J. Launer, and A. Dehghan Genome-wide association study of blood pressure and hypertension Nature Genetics 41 2009 677 687
11. T.A. Manolio, F.S. Collins, N.J. Cox, D.B. Goldstein, L.A. Hindorff, and D.J. Hunter Finding the missing heritability of complex diseases Nature 461 2009 747 753
12. S. Salvoli, M. Capri, A. Santoro, N. Raule, F. Sevini, and S. Lukas The impact of mitochondrial DNA on human lifespan: a view from studies on centenarians Biotechnology Journal 3 2008 740 749
13. S.M. Weakley, J. Jiang, P. Kougias, P.H. Lin, Q. Yao, and F.C. Brunicardi Role of somatic mutations in vascular disease formation Expert Review of Molecular Diagnostics 10 2010 173 185
14. K.D. Coon, J. Valla, S. Szelinger, L.E. Schneider, T.L. Niedzielko, and K.M. Brown Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing Mitochondrion 6 2006 194 210
15. M. Laloi-Michelin, T. Meas, C. Ambonville, C. Bellanné-Chantelot, S. Beaufils, and P. Massin The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes Journal of Clinical Endocrinology and Metabolism 94 2009 3025 3030
16. F. Schwartz, A. Duka, F. Sun, J. Cui, A. Manolis, and H. Gavras Mitochondrial genome mutations in hypertensive individuals The American Journal of Hypertension 17 2004 629 635
17. A.L. Andreu, M.G. Hanna, H. Reichmann, C. Bruno, A.S. Penn, and K. Tanji Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA New England Journal of Medicine 341 1999 1037 1044
18. A.L. Andreu, C. Bruno, T.C. Dunne, K. Tanji, S. Shanske, and C.M. Sue A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria Annals of Neurology 45 1999 127 130
19. American Diabetes Association Standards of medical care in diabetes - 2011 Diabetes Care 34 Suppl. 1 2011 S11 S61
20. B. Balkau, and M.A. Charles Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabetic Medicine 16 1999 442 443
21. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano Guidelines for the management of arterial hypertension. ESC-ESH task force for the management of arterial hypertension Journal of Hypertension 25 2007 1105 1187
22. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2003 2560 2572
23. K. Thygesen, J.S. Alpert, H.D. White, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, A.S. Jaffe, and F.S. Apple Universal definition of myocardial infarction Circulation 116 2007 2634 2653
24. K.M. Thelen, K.M. Rentsch, U. Gutteck, M. Heverin, M. Olin, and U. Andersson Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin Journal of Pharmacology and Experimental Therapeutics 316 2006 1146 1152
25. J. Siedel, E.O. Hagele, J. Ziegenhorn, and A.W. Wahlefeld Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency Clinical Chemistry 29 1983 1075 1080
26. M. Burstein, H.R. Scholnick, and R. Morfin Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions Journal of Lipid Research 11 1970 583 595
27. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 18 1972 499 502
28. S.S. Shapiro, and M.B. Wilk An analysis of variance test for normality (complete samples) Biometrika 52 1965 591 611
29. A.D. Aczel Complete business statistics 2nd ed. 1993 Burr Ridge Irwin
30. W.J. Conover Practical nonparametric statistics 3rd ed. 1999 John Wiley & Sons New York
31. J.M. Bland, and Altman DG Statistics notes. The odds ratio BMJ 320 2000 1468
32. P. Liu, and B. Demple DNA repair in mammalian mitochondria: much more than we thought? Environmental and Molecular Mutagenesis 51 2010 417 426
33. K.J. Krishnan, A.K. Reeve, D.C. Samuels, P.F. Chinnery, J.K. Blackwood, and R.W. Taylor What causes mitochondrial DNA deletions in human cells? Nature Genetics 40 2008 275 279
34. N.R. Madamanchi, and M.S. Runge Mitochondrial dysfunction in atherosclerosis Circulation Research 100 2007 460 473
35. E.L. Blakely, A.L. Mitchell, N. Fisher, B. Meunier, L.G. Nijtmans, and A.M. Schaefer A mitochondrial cytochrome b mutation causing severe respiratory chain enzyme deficiency in humans and yeast FEBS Journal 272 2005 3583 3592
36. J.A. Keightley, R. Anitori, M.D. Burton, F. Quan, N.R. Buist, and N.G. Kennaway Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene American Journal of Human Genetics 67 2000 1400 1410
37. M. Mancuso, M. Filosto, J.C. Stevens, M. Patterson, S. Shanske, and S. Krishna Mitochondrial myopathy and complex III deficiency in a patient with a new stop-codon mutation (G339X) in the cytochrome b gene Journal of the Neurological Sciences 209 2003 61 63
38. S. Khan, G.V. Raghuram, A. Bhargava, N. Pathak, D.H. Chandra, and S.K. Jain Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus Translational Research 158 2011 344 359
39. D.W. Lamson, and S.M. Plaza Mitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment Alternative Medicine Review 7 2002 94 111
40. P.N. Hopkins, L.L. Wu, S.C. Hunt, and E.A. Brinton Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease Journal of the American College of Cardiology 45 2005 1003 1012
41. P.L. da Luz, D. Favarato, J.R. Faria-Neto Jr., P. Lemos, and A.C. Chagas High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease Clinics (Sao Paulo) 63 2008 427 432
42. P.W. Connelly, A. Petrasovits, S. Stachenko, D.R. MacLean, J.A. Little, and A. Chockalingam Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population, Canadian Heart Health Surveys Research Group Canadian Journal of Cardiology 15 1999 428 433
43. C.Y. Chen, C.M. Hwu, M.W. Lin, C.H. Tsai, and H.I. Yeh High triglyceride level is associated with severe coronary artery disease in hypertensive subjects Scandinavian Cardiovascular Journal 42 2008 146 152
44. S. Del Prato Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies Diabetic Medicine 26 2009 1185 1192
45. E. Schulz, T. Gori, and T. Münzel Oxidative stress and endothelial dysfunction in hypertension Hypertension Research 34 2011 665 673
46. T. Watson, P.K. Goon, and G.Y. Lip Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension Antioxidants and Redox Signalling 10 2008 1079 1088